Clin2
NCT06133543Possibly a fitRecruiting

Robotic sentinel node biopsy for testicular cancer

Germ Cell TumorSeminomaNonseminomatous Germ Cell Tumor

Part of Cancer clinical trials.

This trial uses a robot and a special dye (ICG) to find and remove the first lymph node that might contain cancer cells in men with testicular cancer. It aims to reduce unnecessary lymph node removal while still detecting spread.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
44 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You have a testicular tumor confirmed by physical exam and ultrasound, with or without elevated tumor markers (AFP or β-HCG).
  • No signs of cancer spread in CT scans of the chest and abdomen.
  • You are 18 years or older.
  • You can communicate with the study team and understand and sign the consent form.
  • No prior scrotal or retroperitoneal surgery for a non-germ cell tumor, and no prior chemotherapy or radiation to the retroperitoneum.
  • No allergy to ICG dye or iodine, no serious health conditions, and no psychiatric illness.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06144736Recruiting· Phase 2
Surgery for stage 2 seminoma testicular cancer trial

This trial is testing whether removing affected lymph nodes with surgery (RPLND) works well alone for seminoma testicular cancer that has spread to nearby nodes but is still relatively small. It is for patients who have not had extensive chemo or radiation.

Düsseldorf
NCT07054944Not yet recruiting
Better lymph node mapping for solid tumor surgery in children

This study tests a new way to map lymph nodes in children with solid tumors, using a tracer to help doctors see which nodes to remove. The goal is to make lymph node sampling safer and more accurate, which could help guide treatment decisions.

Rochester, New York
NCT07146295Recruiting
ICG dye to find sentinel nodes in breast cancer surgery

This trial tests using a green dye called ICG (indocyanine green) during breast cancer surgery to find the first lymph nodes (sentinel nodes) that cancer may have spread to. It aims to help doctors locate these nodes more accurately, and is for people with early-stage breast cancer that has not yet spread to the lymph nodes.

Alkmaar
NCT07362485Recruiting
Finding sentinel nodes during mastectomy with dye

This trial tests if a special dye (indocyanine green) can find the first lymph nodes (sentinel nodes) during mastectomy. It may help improve staging for women with early breast cancer who need or choose mastectomy.

Zwolle, Overijssel
NCT07699640Not yet recruiting
Removing sentinel lymph nodes for early testicular cancer

This study tests a new, less invasive surgery to check lymph nodes in the back of the abdomen for early testicular cancer. It might help avoid more extensive surgery later by using a special dye to find the nodes that need to be removed.

Helsinki
NCT07777887Recruiting
Finding lymph nodes during testicular cancer surgery

This trial tests a way for surgeons to find the first lymph nodes that testicular cancer might spread to, using a special camera and a dye. It could help doctors decide if you need extra treatment after surgery to remove the testicle.

Saint Petersburg, Sankt-Peterburg

Hear when a new Germ Cell Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.